Actively Recruiting

Phase 3
Age: 18Years - 75Years
FEMALE
ID06144164

A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer to Evaluate a Comprehensive Prevention Program for Lymphedema and Quality of Life

Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-11-10

285

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether a thorough prevention program can help drain lymph fluid from the arm and prevent lymphedema in women diagnosed with breast cancer who undergo axillary lymph node dissection. The study, sponsored by Memorial Sloan Kettering Cancer Center, is a phase 3 prospective cohort study focusing on reducing lymphedema and improving quality of life after treatment for breast cancer. The program includes immediate lymphatic reconstruction performed during axillary lymph node dissection, followed by self-directed lymphatic massage and range of motion exercises starting 24 to 48 hours after surgery. Participants will also use compression garments daily for at least 8 hours a day for 3 months or until 3 months after completing any additional treatments like chemotherapy or radiation. Arm volume measurements will be taken at each in-person postoperative visit to monitor progress. Participants will be involved in regular follow-up visits for up to 24 months, during which their arm volume will be measured to assess changes from baseline. The study tracks adherence to lymphatic massage, exercises, and compression garment use. Researchers will use these assessments to evaluate the program's effect on reducing arm swelling and improving quality of life after breast cancer surgery.

CONDITIONS

Brief Title

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Who Can Participate

Age: 18Years - 75Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female sex
  • Diagnosis of breast cancer
  • Ages 18 to 75 years
  • Consented for unilateral axillary lymph node dissection or for unilateral sentinel lymph node biopsy with possible axillary lymph node dissection
Not Eligible

You will not qualify if you...

  • Male sex
  • Does not speak English
  • Does not fit into study garment
  • Axillary recurrence
  • History of axillary lymph node dissection
  • Requirement of bilateral axillary lymph node dissection for breast cancer treatment
  • Treatment with sentinel lymph node biopsy only
  • Known anaphylactic allergy to indocyanine green dye used in immediate lymphatic reconstruction
  • Impaired decision-making capacity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - At time of surgery and initial recovery period

Participants undergo axillary lymph node dissection with immediate lymphatic reconstruction at the time of surgery. After surgery, participants begin self-directed lymphatic massage and range of motion exercises 24 to 48 hours later, and start daily compression garment use.

1 surgical visit and initial post-operative visit

Post-operative Follow-up

Duration - Up to 3 months or until 3 months after completion of adjuvant treatments

Participants continue lymphatic massage 3 times a week and wear compression garments daily for at least 8 hours a day for 3 months or until 3 months after any adjuvant treatments are completed. Volumetric arm measurements are taken at each in-person post-operative visit to monitor arm volume changes.

Multiple in-person post-operative visits with volumetric arm measurements

Long-term Monitoring

Duration - Up to 24 months

Participants are monitored for changes in arm volume and quality of life for up to 24 months after baseline.

Periodic follow-up visits for arm volume assessments

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Commack (Limited Protocol Activities)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States, 10065

Actively Recruiting

7

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

M

Michelle Coriddi, MD

B

Babak Mahrara, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here